Protean Will Provide Results From a Study of Endometrial Cancer in African Americans and Caucasian Americans at ASCO 2022 in Chicago

 
 

Protean provides results from a study of endometrial cancer in African American and White Americans.

African American patients have a worse outcome, regardless of the molecular subtype of cancer.

In White patients molecular subtypes were associated with better outcomes.

 

The full abstract will be presented at the ASCO Annual Meeting 2022.

 
 
Anthony Magliocco